A comprehensive view of boston scientific corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Boston Scientific recalls Obsidio Conformable Embolic blood flow blocking agent due to safety issues; the product is used to block blood supply to tumors and to treat bleeding in patients
Published:
April 18, 2024
by MedTech Dive
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Neuromodulation for neuroinflammation treatments with parameters controlled using biomarkers" (Texas, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Sensor-based pain management systems and methods" (Minnesota, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Boston Scientific Neuromodulation on April 16 for "Collection of clinical data for graphical representation and analysis" (Ohio, California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION FILES APPLICATION FOR "RF ABLATION SYSTEMS WITH A BIPOLAR RF ELECTRODE AND METHODS FOR MAKING AND USING"
Published:
April 16, 2024
by U.S. Fed News
|
Ask us about our Health Care Sector market view